CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
LenioBio is developing a novel protein production platform, ALiCE®, that enhances the accessibility and affordability of hard-to-produce proteins for biotechnology applications. Their tobacco-based cell-free synthesis technology offers higher yields and stability, targeting pharmaceutical and agricultural sectors.
The companyLenioBio is a biotech company that develops and markets a novel, unique and proprietary protein production platform, ALiCE®, which enables protein-based therapeutics to become more accessible and affordable and specifically
targeting the substantial but underserved class of ‘difficult-to-express (DTE) proteins’.LenioBio has developed a proprietary tobacco-based cell-free protein synthesis (CFPS) platform “ALiCE” with a higher yield (3 mg/ml) than any other
eukaryotic cell-free system…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
